肿瘤科指南

订阅

MedSci主页 / 所有栏目 / 肿瘤科指南

2020 ESMO建议：COVID-19流行期间肺癌的管理和治疗

2020-06-05 欧洲肿瘤内科学会 ESMO Open . 2020 Jun;5(Suppl 3):e000820.

肺癌 COVID-19

2020年6月，欧洲肿瘤内科学会(ESMO)发布了COVID-19流行期间肺癌的管理和治疗建议。COVID-19的流行推进了一系列结构化癌症护理管理建议的制定，本文主要针对疫情期间肺癌的管理和治疗提供

中文标题：

2020 ESMO建议：COVID-19流行期间肺癌的管理和治疗

英文标题：

ESMO Management and Treatment Adapted Recommendations in the COVID-19 Era: Lung Cancer

发布机构：

欧洲肿瘤内科学会

发布日期：

2020-06-05

简要介绍：

2020年6月，欧洲肿瘤内科学会(ESMO)发布了COVID-19流行期间肺癌的管理和治疗建议。COVID-19的流行推进了一系列结构化癌症护理管理建议的制定，本文主要针对疫情期间肺癌的管理和治疗提供指导建议。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2020 ESMO建议：COVID-19流行期间肺癌的管理和治疗.pdf)] GetToolGuiderByIdResponse(projectId=1, id=20e1f1c001938a6f, title=2020 ESMO建议：COVID-19流行期间肺癌的管理和治疗, enTitle=ESMO Management and Treatment Adapted Recommendations in the COVID-19 Era: Lung Cancer, guiderFrom=ESMO Open . 2020 Jun;5(Suppl 3):e000820., authorId=0, author=, summary=2020年6月，欧洲肿瘤内科学会(ESMO)发布了COVID-19流行期间肺癌的管理和治疗建议。COVID-19的流行推进了一系列结构化癌症护理管理建议的制定，本文主要针对疫情期间肺癌的管理和治疗提供, cover=https://img.medsci.cn/2020721/1595341140537_2020535.jpg, journalId=0, articlesId=null, associationId=14, associationName=欧洲肿瘤内科学会, associationIntro=欧洲肿瘤内科学会（ESMO，European Society for Medical Oncology )是1975年成立的非盈利组织，是欧洲领先的专业组织，致力于提高肿瘤内科的专业性，推进癌症治疗和护理的多学科诊疗方法。, copyright=0, guiderPublishedTime=Fri Jun 05 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2020年6月，欧洲肿瘤内科学会(ESMO)发布了COVID-19流行期间肺癌的管理和治疗建议。COVID-19的流行推进了一系列结构化癌症护理管理建议的制定，本文主要针对疫情期间肺癌的管理和治疗提供指导建议。</p> </div> </div> </div>, tagList=[TagDto(tagId=428, tagName=肺癌), TagDto(tagId=102190, tagName= COVID-19)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=12, categoryName=呼吸, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=20620, categoryName=肿瘤医学网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=428, guiderKeyword=肺癌, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3032, appHits=69, showAppHits=0, pcHits=525, showPcHits=2963, likes=0, shares=2, comments=19, approvalStatus=1, publishedTime=Wed Jul 22 01:30:05 CST 2020, publishedTimeString=2020-06-05, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Tue Jul 21 22:19:07 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Fri Jan 05 18:38:23 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2020 ESMO建议：COVID-19流行期间肺癌的管理和治疗.pdf)])
2020 ESMO建议：COVID-19流行期间肺癌的管理和治疗.pdf
下载请点击：
评论区 (12)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=895140, encodeId=ca3d895140ba, content=怎么获得积分呢？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201111/d0280f69d64e489d98c57b480cb9f03d/71eaa0bd19cc4d39b773901c2f0cb086.jpg, createdBy=275d5429877, createdName=fffuturee, createdTime=Wed Oct 28 18:36:03 CST 2020, time=2020-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904551, encodeId=6989904551d4, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/bAIbPo8Kvb0ibEdUBqAwickON6cAuRuNYV6g7YaTA3AJTjSxMsanNPibnH5XxU5Mkg0Qykj97bS1ODiaL8Kb0vsmnw/132, createdBy=0b005291298, createdName=如是真我, createdTime=Thu Dec 03 11:57:57 CST 2020, time=2020-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895181, encodeId=2c59895181c1, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/13/bce116f3143d02835c5907e0ad2b13a1.jpg, createdBy=a9551679187, createdName=kenblue, createdTime=Wed Oct 28 21:01:50 CST 2020, time=2020-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883335, encodeId=3bf488333503, content=我也需要积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50042599871, createdName=76442351, createdTime=Mon Sep 07 16:04:38 CST 2020, time=2020-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=809434, encodeId=0b06809434ed, content=建议可以买积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=373b5135686, createdName=老KK, createdTime=Sun Aug 16 20:13:50 CST 2020, time=2020-08-16, status=1, ipAttribution=)]
    2020-10-28 fffuturee

    怎么获得积分呢？

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=895140, encodeId=ca3d895140ba, content=怎么获得积分呢？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201111/d0280f69d64e489d98c57b480cb9f03d/71eaa0bd19cc4d39b773901c2f0cb086.jpg, createdBy=275d5429877, createdName=fffuturee, createdTime=Wed Oct 28 18:36:03 CST 2020, time=2020-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904551, encodeId=6989904551d4, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/bAIbPo8Kvb0ibEdUBqAwickON6cAuRuNYV6g7YaTA3AJTjSxMsanNPibnH5XxU5Mkg0Qykj97bS1ODiaL8Kb0vsmnw/132, createdBy=0b005291298, createdName=如是真我, createdTime=Thu Dec 03 11:57:57 CST 2020, time=2020-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895181, encodeId=2c59895181c1, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/13/bce116f3143d02835c5907e0ad2b13a1.jpg, createdBy=a9551679187, createdName=kenblue, createdTime=Wed Oct 28 21:01:50 CST 2020, time=2020-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883335, encodeId=3bf488333503, content=我也需要积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50042599871, createdName=76442351, createdTime=Mon Sep 07 16:04:38 CST 2020, time=2020-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=809434, encodeId=0b06809434ed, content=建议可以买积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=373b5135686, createdName=老KK, createdTime=Sun Aug 16 20:13:50 CST 2020, time=2020-08-16, status=1, ipAttribution=)]
    2020-12-03 如是真我

    学习学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=895140, encodeId=ca3d895140ba, content=怎么获得积分呢？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201111/d0280f69d64e489d98c57b480cb9f03d/71eaa0bd19cc4d39b773901c2f0cb086.jpg, createdBy=275d5429877, createdName=fffuturee, createdTime=Wed Oct 28 18:36:03 CST 2020, time=2020-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904551, encodeId=6989904551d4, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/bAIbPo8Kvb0ibEdUBqAwickON6cAuRuNYV6g7YaTA3AJTjSxMsanNPibnH5XxU5Mkg0Qykj97bS1ODiaL8Kb0vsmnw/132, createdBy=0b005291298, createdName=如是真我, createdTime=Thu Dec 03 11:57:57 CST 2020, time=2020-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895181, encodeId=2c59895181c1, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/13/bce116f3143d02835c5907e0ad2b13a1.jpg, createdBy=a9551679187, createdName=kenblue, createdTime=Wed Oct 28 21:01:50 CST 2020, time=2020-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883335, encodeId=3bf488333503, content=我也需要积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50042599871, createdName=76442351, createdTime=Mon Sep 07 16:04:38 CST 2020, time=2020-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=809434, encodeId=0b06809434ed, content=建议可以买积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=373b5135686, createdName=老KK, createdTime=Sun Aug 16 20:13:50 CST 2020, time=2020-08-16, status=1, ipAttribution=)]
    2020-10-28 kenblue

    学习学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=895140, encodeId=ca3d895140ba, content=怎么获得积分呢？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201111/d0280f69d64e489d98c57b480cb9f03d/71eaa0bd19cc4d39b773901c2f0cb086.jpg, createdBy=275d5429877, createdName=fffuturee, createdTime=Wed Oct 28 18:36:03 CST 2020, time=2020-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904551, encodeId=6989904551d4, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/bAIbPo8Kvb0ibEdUBqAwickON6cAuRuNYV6g7YaTA3AJTjSxMsanNPibnH5XxU5Mkg0Qykj97bS1ODiaL8Kb0vsmnw/132, createdBy=0b005291298, createdName=如是真我, createdTime=Thu Dec 03 11:57:57 CST 2020, time=2020-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895181, encodeId=2c59895181c1, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/13/bce116f3143d02835c5907e0ad2b13a1.jpg, createdBy=a9551679187, createdName=kenblue, createdTime=Wed Oct 28 21:01:50 CST 2020, time=2020-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883335, encodeId=3bf488333503, content=我也需要积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50042599871, createdName=76442351, createdTime=Mon Sep 07 16:04:38 CST 2020, time=2020-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=809434, encodeId=0b06809434ed, content=建议可以买积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=373b5135686, createdName=老KK, createdTime=Sun Aug 16 20:13:50 CST 2020, time=2020-08-16, status=1, ipAttribution=)]
    2020-09-07 76442351

    我也需要积分

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=895140, encodeId=ca3d895140ba, content=怎么获得积分呢？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201111/d0280f69d64e489d98c57b480cb9f03d/71eaa0bd19cc4d39b773901c2f0cb086.jpg, createdBy=275d5429877, createdName=fffuturee, createdTime=Wed Oct 28 18:36:03 CST 2020, time=2020-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904551, encodeId=6989904551d4, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/bAIbPo8Kvb0ibEdUBqAwickON6cAuRuNYV6g7YaTA3AJTjSxMsanNPibnH5XxU5Mkg0Qykj97bS1ODiaL8Kb0vsmnw/132, createdBy=0b005291298, createdName=如是真我, createdTime=Thu Dec 03 11:57:57 CST 2020, time=2020-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895181, encodeId=2c59895181c1, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/13/bce116f3143d02835c5907e0ad2b13a1.jpg, createdBy=a9551679187, createdName=kenblue, createdTime=Wed Oct 28 21:01:50 CST 2020, time=2020-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883335, encodeId=3bf488333503, content=我也需要积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50042599871, createdName=76442351, createdTime=Mon Sep 07 16:04:38 CST 2020, time=2020-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=809434, encodeId=0b06809434ed, content=建议可以买积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=373b5135686, createdName=老KK, createdTime=Sun Aug 16 20:13:50 CST 2020, time=2020-08-16, status=1, ipAttribution=)]
    2020-08-16 老KK

    建议可以买积分

    0

以上为热门评论，梅斯医学App还有更多内容

相关指南

2020 ESTRO/ASTRO共识声明：COVID-19流行期间肺癌放射治疗的实践建议

欧洲放射肿瘤学学会(ESTRO,European Society of Radiotherapy & Oncology) · 2020-06-28

中华医学会肺癌临床诊疗指南（2019版）

中华医学会(CMA,Chinese Medical Association) · 2020-04-30

2020 ESTRO/ASTRO共识声明：COVID-19流行期间肺癌的放疗建议

欧洲放射肿瘤学学会(ESTRO,European Society of Radiotherapy & Oncology) · 2020-04-06

晚期非小细胞肺癌临床试验终点技术指导原则

国家药品监督管理局药品审评中心（CDE） · 2019-10-30

2019 NICE指南：肺癌的诊断和管理（NG.122）

暂未更新 · 2019-03-28

抗肿瘤药物处方审核专家共识—肺癌

中国抗癌协会(Chinese Anti-cancer Association) · 2019-05-30

拓展阅读

2014 IASLC肺癌分期项目：肺癌TNM分期新数据（第八版）

国际肺癌研究协会(IASLC,International Association for the Study of Lung Cancer) · 2014-09-14

中国原发性肺癌诊疗规范（2015年版）

中华人民共和国国家卫生和计划生育委员会(NHFPC,National Health and Family Planning Commission of China) · 2015-01-29

中国晚期原发性肺癌诊治专家共识(2016年版)

暂未更新 · 2016-04-21

2014 IASLC/ASCO：肺癌患者表皮生长因子受体和间变性淋巴瘤激酶酪氨酸激酶抑制剂的选择性分子检测

美国临床肿瘤学会(ASCO,American Society of Clinical Oncology) · 2016-05-31

2016 中国非小细胞肺癌患者表皮生长因子受体基因突变检测专家共识

中华医学会病理学分会 · 2016-04-30

回生口服液用于非小细胞肺癌围手术期抗凝治疗专家共识（2016版）

中国肿瘤科相关专家小组（统称） · 2016-11-01